Status:
COMPLETED
Usefulness of Integrated PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Oropharyngeal Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
Head and neck cancer (HNC) continues to be a significant health care problem in Taiwan and oropharyngeal squamous cell carcinoma (SCC) is the common subtype. With the concern of organ preservation in ...
Detailed Description
In this three-year prospective project, a total of 160 patients with histologically proven oropharyngeal SCC subjected to chemoradiation will be enrolled. Exclusion criteria include previous head or n...
Eligibility Criteria
Inclusion
- histologically proven oropharyngeal SCC subjected to chemoradiation
Exclusion
- previous head or neck malignant tumor, a second malignant tumor, distant metastasis, contraindications to MRI (renal insufficiency, cochlear implant, cardiac pacemaker
Key Trial Info
Start Date :
August 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
233 Patients enrolled
Trial Details
Trial ID
NCT05299957
Start Date
August 1 2015
End Date
December 31 2021
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital
Guishan, Taoyuan, Taiwan, 333